Iván Romarico González Espinoza
Iván Romarico González Espinoza publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Pancreatic and Hepatic Oncology Research, Global Cancer Incidence and Screening and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #3,380,273 of 7,710,434 ranked researchers
- Rank in Mexico
- #11,113 of 55,557
- Works
- 19
- Citations
- 88
- Citations per work
- 4.6
What does Iván Romarico González Espinoza research?
Iván Romarico González Espinoza's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1159.3%
- Medicine1159.3%
- Everything else735.1%
- Life Sciences15.6%
- 1Oncology28% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Surgery7% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Molecular Biology6% of their works
- 6Hepatology4% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Global Cancer Incidence and Screening
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer survivorship and care
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Radiomics and Machine Learning in Medical Imaging
Which keywords describe Iván Romarico González Espinoza's research?
The keywords of their largest research topics: Chemotherapy, Immunotherapy, Clinical Practice Guidelines, Pancreatic Cancer, Precision Medicine, Surgical Complications, Cancer Incidence and Mortality Rates.
- Small-Cell Lung Cancer
- Quality of Life
- Liver Cancer
- Hepatocellular Carcinoma
- Gastric Cancer
- Cetuximab
- Mortality Rates
- Surgical Complications
- Pancreatic Cancer
- Immunotherapy
- Chemotherapy
- Clinical Practice Guidelines
- Precision Medicine
- Cancer Incidence
- Cancer Survivorship
- Endoscopic Resection
- Genomic Profiles
- KRAS Mutations
- Medical Imaging
- Radiomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy104 topics
- Immunotherapy62 topics
- Clinical Practice Guidelines42 topics
- Pancreatic Cancer41 topic
- Precision Medicine42 topics
- Surgical Complications41 topic
- Cancer Incidence31 topic
- Mortality Rates31 topic
- Cancer Survivorship21 topic
- Cetuximab21 topic
- Endoscopic Resection21 topic
- Gastric Cancer21 topic
- Genomic Profiles21 topic
- Hepatocellular Carcinoma21 topic
- KRAS Mutations21 topic
- Liver Cancer21 topic
- Medical Imaging21 topic
- Quality of Life21 topic
- Radiomics21 topic
- Small-Cell Lung Cancer21 topic
Where does Iván Romarico González Espinoza work?
Iván Romarico González Espinoza's main affiliation in the publication record is Clínica Ruiz, Mexico.
How many publications and citations does Iván Romarico González Espinoza have?
OpenAlex counts 19 works and 88 citations for Iván Romarico González Espinoza, an h-index of 3, ranking #3,380,273 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Iván Romarico González Espinoza. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.